Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Product/Service, Merger/Acquisition

Boomi Doubles Down on API Management with Key Acquisitions


Boomitm, the intelligent integration and automation leader, today announced the acquisitions of APIIDA's federated API management business and API management assets from Cloud Software Group, allowing enterprises to rapidly and securely deliver business value through API products in one end-to-end platform. Both these acquisitions accelerate Boomi's roadmap for providing solutions to the most pressing API management challenges that companies face today.

"APIs are the backbone of modern software and application development, and have become a cornerstone of modern architectures that enable businesses to stay agile and compete effectively," said Steve Lucas, CEO at Boomi. "However, cloud adoption and the explosive growth of APIs have disrupted traditional IT infrastructures. With these acquisitions, we're putting an end to operational overhead and API sprawl by offering a robust, enterprise-grade and federated API management solution, giving customers the ability to quickly provision, discover, secure, and infinitely scale in one end-to-end enterprise platform."

APIIDA Federated API Management

As the market-leading solution for federated API management, APIIDA's API Control Plane expands Boomi's portfolio by offering the ability for enterprises to discover, govern, and provision APIs from one central place, including APIs managed through gateways from various vendors. This allows a vendor-agnostic, federated administration of the entire API lifecycle, and can be adapted to the requirements of any organization, enabling a consistent consumer experience and governance across all APIs.

By offering federated API management, Boomi enables enterprises to:

"Companies that rely on a manual, fragmented approach to registering, managing, and publishing APIs across distributed platforms risk having those APIs be undiscovered, overlooked, and hence unadopted by users and applications that could benefit from them," said Jaime Ryan, Vice President of Product, API Management at Boomi. "To successfully enable digital transformation, businesses need a proven, reliable way to connect applications and other data sources. With federated API management, customers will be able to reduce time to value with a single control plane for wherever APIs are deployed, providing better discovery, governance, and collaboration while making existing APIs more visible, subscribable, and consumable."

API Management Assets From Cloud Software Group

Further accelerating the company's API management roadmap, Boomi has also acquired assets from Cloud Software Group, providing Boomi customers enterprise-grade scalability and security. These assets, developed by a team that helped invent the API economy and used by some of the world's largest organizations, will enable the Boomi Enterprise Platform to support even the most demanding API management performance and security requirements in markets such as travel, retail, tech, finance, and healthcare.

Additional Resources

About Boomi

Boomi powers the future of business with intelligent integration and automation. As a category-leading, global software as a service (SaaS) company, Boomi celebrates more than 20,000 global customers and a worldwide network of 800 partners. Organizations turn to Boomi's award-winning platform to connect their applications, data, and people to accelerate digital transformation. For more information, visit boomi.com.

© 2024 Boomi, LP. Boomi, the ?B' logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...



News published on and distributed by: